★
BLFS
BioLife Solutions Inc · Life Sciences Tools & Services
FCF$8mC-
Rev+34.0%A
D/E0.01A
P/S11.7xC
PEG——
69Score
$24.031Y Target$32.44Near-term target
5Y Target$48.33Compound horizon
10Y Target$125.77Long-dated conviction
FCF$8mTTM · 03/26C-
FCF $8m — barely positive; fragile cash position · TTM computed from 4 most-recent quarters (TTM · 03/26).
Rev+34.0%TTM YoYA
Revenue +34.0% — hypergrowth, top decile · TTM YoY from trailing-4-quarter revenue sum vs prior 4 quarters.
D/E0.01totalA
D/E 0.01 — essentially debt-free, pristine balance sheet · Total D/E computed from balance sheet (short-term + long-term debt + lease obligations) ÷ stockholders equity. More accurate than native field, which often uses long-term debt only.
P/S11.7xC
P/S 11.7x — elevated; requires growth to justify
PEG—proxy—
PEG not meaningful — earnings growth negative or data unavailable · PEG proxy: P/E ÷ revenue growth % (true PEG requires forward EPS estimates, not in Finnhub free tier).
Why now
Life Sciences Tools & Services · market cap $1.2b. 19% off the 52-week high of $29.62. Revenue growing +34% — in hypergrowth territory.
Moat
Speculative bucket — the moat thesis is forward-looking; without proven margin structure or capital efficiency yet, the durability argument is about IP / network effects / first-mover position that the company hasn't fully monetized.
Risk
Currently unprofitable (margin -3.0%) — path to GAAP profitability is the core thesis risk. Beta 1.98 implies above-market volatility — position-size to the drawdowns this name will produce in a market correction, not to its bull-case return. P/S 11.7x embeds aggressive forward growth — disappointing top-line guidance would compress the multiple hard.
Horizon
1-3 yr $32.44 (structural (no analyst coverage)) — catalyst-driven; binary events dominate. 5 yr $48.33 — requires the platform / technology to reach commercial scale. 10 yr $125.77 — return distribution heavily skewed.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.
Position sizing · BLFS
Shares to buy
83
Position size
$1,994
4.0% of portfolio
Stop price
$18.02
25% below $24.03
$ at risk
$500.00
1% of portfolio
Math only — share count is floor(portfolio × risk% ÷ (price × stop%)). Doesn't account for commissions, slippage, gap risk, or position-correlation across your book. Inputs persist locally; never sent to the server. Not investment advice.